TROY EDWARD WILSON
CIK 1589597 · President and CEO · last filed 2026-03-25
TROY EDWARD WILSON is a President and CEO who has filed 67 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing shows the insider exercised options covering $37.5K of KURA on Mar 25, 2026. Across all open-market trades the lifetime net is −$24.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.00M
5
67
-$24.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | President and CEO | 714,650 | $9.05 | $6.47M | -$18.19M | 30 | 2026-03-25 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Director | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Director | 97,636 | $12.37 | $1.21M | -$5.75M | 10 | 2025-09-09 |
| PBYI | Director | 43,950 | $7.33 | $322.2K | -$836.0K | 20 | 2025-06-17 |
| Zosano Pharma Corp (ZSAN) Delisted | Director | 3,000 | $0.56 | $1.7K | $0 | 5 | 2019-07-18 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-25 | KURA | Exer (M) | +6,103 | $37.5K | EDGAR |
| 2026-03-02 | — | Grant (A) | — | $0 | |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −78,802 | $0 | EDGAR |
| 2026-01-06 | KURA | Grant (A) | — | $0 | EDGAR |
| 2025-11-14 | KURA | Grant (A) | +182,500 | $0 | EDGAR |
| 2025-09-29 | KURA | Mixed | +145,885 | -$327.4K | EDGAR |
| 2025-09-09 | KURA | Buy (P) | +50,000 | $410.1K | EDGAR |
| 2025-09-09 | RNA | Mixed | −15,000 | -$1.29M | EDGAR |
| 2025-08-14 | KURA | Buy (P) | +50,000 | $303.2K | EDGAR |
| 2025-08-08 | RNA | Mixed | −65,554 | -$3.92M | EDGAR |